Legacy Pharmaceutical Packaging LLC is recalling 179,544 bottles of Losartan Potassium (50 mg) tablets because testing detected an impurity called N-Methylnitrosobutyric acid (NMBA). This prescription blood pressure medication was packaged in 30-count bottles and distributed to Kroger pharmacies in Arizona, Indiana, and Tennessee. Consumers should continue taking their medication but contact their doctor or pharmacist immediately to discuss an alternative treatment, as the risk of stopping blood pressure medication suddenly may be higher than the risk of the impurity.
The tablets contain NMBA, which is a known environmental contaminant and a potential human carcinogen. Exposure to this impurity over a long period may increase the risk of cancer.
Healthcare consultation and pharmacy refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.